HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,887 | +8.1% | 8,662 | +2.1% | 0.00% | – |
| Q2 2023 | $306,126 | -7.6% | 8,487 | -2.1% | 0.00% | -100.0% |
| Q1 2023 | $331,222 | -41.9% | 8,673 | -13.5% | 0.00% | 0.0% |
| Q4 2022 | $570,309 | +27.6% | 10,023 | -11.3% | 0.00% | 0.0% |
| Q3 2022 | $447,000 | -8.2% | 11,305 | +2.1% | 0.00% | 0.0% |
| Q2 2022 | $487,000 | -3.8% | 11,069 | -12.6% | 0.00% | 0.0% |
| Q1 2022 | $506,000 | +42.9% | 12,663 | +43.8% | 0.00% | 0.0% |
| Q4 2021 | $354,000 | -20.3% | 8,804 | -19.3% | 0.00% | 0.0% |
| Q3 2021 | $444,000 | -19.7% | 10,908 | -10.5% | 0.00% | 0.0% |
| Q2 2021 | $553,000 | +2.4% | 12,189 | -5.9% | 0.00% | 0.0% |
| Q1 2021 | $540,000 | +24.4% | 12,950 | +27.3% | 0.00% | 0.0% |
| Q4 2020 | $434,000 | +95.5% | 10,175 | +20.4% | 0.00% | 0.0% |
| Q3 2020 | $222,000 | -1.8% | 8,448 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $226,000 | +66.2% | 8,448 | +11.8% | 0.00% | – |
| Q1 2020 | $136,000 | +51.1% | 7,555 | +48.5% | 0.00% | – |
| Q4 2019 | $90,000 | +42.9% | 5,088 | +25.8% | 0.00% | – |
| Q3 2019 | $63,000 | -58.0% | 4,045 | -53.8% | 0.00% | – |
| Q2 2019 | $150,000 | +10.3% | 8,761 | +3.3% | 0.00% | – |
| Q1 2019 | $136,000 | +13.3% | 8,479 | +3.3% | 0.00% | – |
| Q4 2018 | $120,000 | -6.2% | 8,208 | +16.4% | 0.00% | – |
| Q3 2018 | $128,000 | +88.2% | 7,052 | +74.3% | 0.00% | – |
| Q2 2018 | $68,000 | -13.9% | 4,045 | 0.0% | 0.00% | – |
| Q1 2018 | $79,000 | -3.7% | 4,045 | 0.0% | 0.00% | – |
| Q4 2017 | $82,000 | +17.1% | 4,045 | 0.0% | 0.00% | – |
| Q3 2017 | $70,000 | -29.3% | 4,045 | -64.6% | 0.00% | – |
| Q2 2016 | $99,000 | -8.3% | 11,430 | 0.0% | 0.00% | – |
| Q1 2016 | $108,000 | – | 11,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |